AKR1B1 and kidney disorder: Numerous studies have investigated the inhibitory effects of synthetic and natural compounds on aldose reductase to mitigate the chronic complications of diabetes, such as nephropathy, retinopathy, and neuropathy (Gamal and Munusamy, 2017; Dănilă et al., 2024).